ALS

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression

Clinical recognition and management of amyotrophic lateral sclerosis

A Pilot Trial of Pioglitazone HCl and Tretinoin in ALS: Cerebrospinal Fluid Biomarkers to Monitor Drug Efficacy and Predict Rate of Disease Progression,

Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder.

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Whole-genome analysis of sporadic amyotrophic lateral sclerosis.

A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS.

A pilot trial of memantine and riluzole in ALS: Correlation to CSF biomarkers

CIDP

Treatment of IgM antibody associated polyneuropathies using rituximab.
IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.

Distal acquired demyelinating symmetric neuropathy.

Clinical spectrum of chronic acquired demyelinating polyneuropathies.

Chronic Inflammatory Demyelinating Polyneuropathy

Dermatomyositis

Acthar in Dermatomyositis and Polymyositis Treatment Registry: An Interim Analysis (593k PDF)
Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series.
History of dermatomyositis
Rituximab in the treatment of dermatomyositis: an open-label pilot study.

Guillain Barre

Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy.

Inclusion Body Myositis

Interim Analysis of A Pilot Trial of Natalizumab in Inclusion Body Myositis (458k PDF)

Pilot trial of etanercept in the treatment of inclusion-body myositis.

Muscular Dystrophy

Clinical and genetic aspects of distal myopathies.

Multiple Sclerosis

Exploring the Clinical Course of Hair Thinning Associated With Teriflunomide: An Update to the Teriflunomide Real-World Case Series (792k PDF)

ALLOW – A Phase 3b Trial Characterising Flu-like Symptoms in Patients Transitioning to Pegylated Interferon Beta-1a: Interim Analysis of all Patients

The Delphi Method on Peginterferon Beta-1 Injection Site Reactions and Management Strategies in the Relapsing-Remitting Multiple Sclerosis ALLOW Study

Glatiramer acetate in the reduction of relapse frequency in multiple sclerosis

Clinical recognition and management of amyotrophic lateral sclerosis.

Clinical, biochemical and imaging parameters that may be predictive of high disease activity, rapid progression or increased disability in multiple sclerosis.

Glatiramer acetate in the reduction of relapse frequency in multiple sclerosis.

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Avonex Combination Trial in relapsing–remitting MS: rationale, design and baseline data.

Myasthenia Gravis

Retrospective review of the safety of Hizentra in neuromuscular patients with renal failure (845k PDF)

Management of myasthenia gravis.

Peripheral Neuropathy

Usefulness of Skin Biopsies in the Evaluation and Management of Patients with Suspected Small Fiber Neuropathy.

Chronic cryptogenic sensory polyneuropathy: clinical and laboratory characteristics.
Challenges in the identification of cobalamin-deficiency polyneuropathy.

Treatment of IgM antibody associated polyneuropathies using rituximab.

IgM antibody-related polyneuropathies: B-cell depletion chemotherapy using Rituximab.

Chronic acquired demyelinating polyneuropathies.

Treatment recommendations in Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia.

Peripheral neuropathies in Waldenström’s macroglobulinaemia.

Peripheral neuropathy in an outpatient cohort of patients with Sjögren’s syndrome.

Polymyositis

Treating refractory dermatomyositis or polymyositis with adrenocorticotropic hormone gel: a retrospective case series

Inflammatory myopathy with cytochrome oxidase negative muscle fibers: methotrexate treatment.

Small Fiber Neuropathy

Small Fiber Neuropathy in Patients Meeting Diagnostic Criteria for Fibromyalgia

Other

Muscle channelopathies.